The Recall Desk
ModerateFDA (Drugs)·D-0059-2025·Announced 2024-11-27

Calcium Antacid (Calcium Carbonate) Recall Due to Blister Packaging Separation

Safecor Health recalls 791 boxes of Calcium Carbonate chewable tablets (Lot 24A0073) due to cGMP deviations where blister card-foils separated from blister cavities.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall for a manufacturing quality control defect (blister packaging separation). No specific hazard indicators such as pathogens, allergens, or reported injuries are mentioned in the source.

Plain-English summary

Safecor Health, LLC has recalled 791 boxes of CALCIUM ANTACID (Calcium Carbonate) Chewable 500 mg tablets due to cGMP manufacturing deviations. The recalled product is identified by lot number 24A0073 with an expiration date of June 28, 2026, and is packaged as a 100-count unit dose box.

During quality control inspections, observations were made that some blister card-foils were separating from the blister cavity. The FDA classified this as a Class II recall.

The affected product was distributed nationwide throughout the United States. Consumers who have purchased this product with the identified lot number should discontinue use and contact their healthcare provider with any concerns.

The recalled product

Product
CALCIUM ANTACID (CALCIUM CARBONATE)
Brand
CALCIUM ANTACID
Manufacturer
Safecor Health, LLC
Category
Drug — OTC Antacid
Hazard
  • packaging-defect

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot# 24A0073
  • exp. date 06/28/2026

Distribution

Distributed nationwide across the United States.

Related recalls

Same category